https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/fda-statement-voluntary-withdrawal-raptiva-us-market
FDA Statement on the Voluntary Withdrawal of Raptiva From the U.S. Market | FDA
fda statementon the
https://www.amgen.com/tavneos-prescribers
Amgen Statement on FDA Data Submission for TAVNEOS® (avacopan) | Amgen
Amgen Statement on FDA Data Submission for TAVNEOS® (avacopan)
data submissionamgenstatementfdaavacopan
https://www.prnewswire.com/news-releases/statement-from-acting-fda-commissioner-ned-sharpless-md-on-continued-efforts-to-increase-availability-of-all-forms-of-naloxone-to-help-reduce-opioid-overdose-deaths-300922456.html
Statement from Acting FDA Commissioner Ned Sharpless, M.D., on continued efforts to increase...
/PRNewswire/ -- Addressing opioid overdose continues to be one of the most urgent public health priorities for the U.S. government and making potentially...
https://www.idsociety.org/news--publications-new/articles/2021/statement-on-fda-authorization-of-supplemental-vaccine-dose-for-immunocompromised-patients/
Statement on FDA Authorization of Supplemental Vaccine Dose for Immunocompromised Patients
statementfdaauthorization
https://3dprintingindustry.com/news/fda-makes-statement-concerning-future-3d-printing-medicine-125627/
FDA makes statement concerning the future of 3D printing in medicine - 3D Printing Industry
Dec 5, 2017 - The increasing availability of 3D printed medical devices, like hip implants or cranial plates, and the potential benefits of 3D printed drugs, makes additive...
the future of
https://asm.org/articles/policy/2020/october/asm-statement-on-the-fda-guidance-on-euas-for-covi
ASM Statement on the FDA Guidance on EUAs for COVID-19 Vaccines
ASM issued the following statement supporting FDA's guidance for emergency use authorization for COVID-19 vaccines.
on thefda guidanceasmstatement